 | • レポートコード：QYR9N8049 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、皮膚ガンのグローバル市場について調査・分析したレポートで、種類別（基底細胞がん、扁平上皮がん）、用途別（病院、診療所、診断センター、がん研究所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・皮膚ガンの世界市場規模 ・主要企業別市場シェア ・皮膚ガンの世界市場規模：種類別（基底細胞がん、扁平上皮がん） ・皮膚ガンの世界市場規模：用途別（病院、診療所、診断センター、がん研究所） ・皮膚ガンのアメリカ市場規模（種類別、用途別） ・皮膚ガンのヨーロッパ市場規模（種類別、用途別） ・皮膚ガンの中国市場規模（種類別、用途別） ・皮膚ガンの日本市場規模（種類別、用途別） ・皮膚ガンの東南アジア市場規模（種類別、用途別） ・皮膚ガンのインド市場規模（種類別、用途別） ・皮膚ガンの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・皮膚ガンの世界市場予測（2019年-2025年） ・皮膚ガンの地域別市場予測（2019年-2025年） ... |
Skin cancer is the most common type of cancer, which arise due to uncontrolled growth of abnormal skin cells. It occurs when skin cells are damaged by unrepaired DNA or genetic defects that lead the uncontrolled growth of cells in the skin.Asia Pacific is the fastest growing skin cancer market. Japan, Australia, and China are the major contributor to the market growth. The incidence of skin cancer per 100,000 population is 20-25 cases in Japan, 11-12 cases in China. About 80% of the cases are basal cell carcinoma (BCC), 16% squamous cell carcinoma, and 4% are melanoma.
In 2018, the global Skin Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Skin Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Skin Cancer development in United States, Europe and China.
The key players covered in this study
F. Hoffmann-la Roche Ltd. (Switzerland)
Novartis International AG (Switzerland)
Sun Pharma Industries Ltd. (India)
Elekta AB (Sweden)
Varian Medical Systems Inc. (US)
Cannabis Science Inc. (US)
Cellceutix Corp. (US)
LEO Pharma A/S (Denmark)
Moberg Pharma AB (Sweden)
Mylan Pharmaceutical Inc. (US)
Oncothyreon Inc. (US)
Eli Lilly and Co. (US)
Bristol Myers Squibb Co. (US)
Boehringer Ingelheim GmbH (Germany)
Aqua Pharmaceuticals LLC (US)
Valeant Pharmaceuticals Inc (Canada)
Meda AB (US)
iCAD Inc. (Sweden)
Merck & Co. Inc. (US)
Market segment by Type, the product can be split into
Basal Cell Carcinoma
Squamous Cell Carcinoma
Market segment by Application, split into
Hospital
Clinics
Diagnostic Centers
Cancer Research Institute
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Skin Cancer status, future forecast, growth opportunity, key market and key players.
To present the Skin Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Skin Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Skin Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 Basal Cell Carcinoma
1.4.3 Squamous Cell Carcinoma
1.5 Market by Application
1.5.1 Global Skin Cancer Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Cancer Research Institute
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Skin Cancer Market Size
2.2 Skin Cancer Growth Trends by Regions
2.2.1 Skin Cancer Market Size by Regions (2014-2025)
2.2.2 Skin Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Skin Cancer Market Size by Manufacturers
3.1.1 Global Skin Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Skin Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Skin Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Skin Cancer Key Players Head office and Area Served
3.3 Key Players Skin Cancer Product/Solution/Service
3.4 Date of Enter into Skin Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Skin Cancer Market Size by Type (2014-2019)
4.2 Global Skin Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Skin Cancer Market Size (2014-2019)
5.2 Skin Cancer Key Players in United States
5.3 United States Skin Cancer Market Size by Type
5.4 United States Skin Cancer Market Size by Application
6 Europe
6.1 Europe Skin Cancer Market Size (2014-2019)
6.2 Skin Cancer Key Players in Europe
6.3 Europe Skin Cancer Market Size by Type
6.4 Europe Skin Cancer Market Size by Application
7 China
7.1 China Skin Cancer Market Size (2014-2019)
7.2 Skin Cancer Key Players in China
7.3 China Skin Cancer Market Size by Type
7.4 China Skin Cancer Market Size by Application
8 Japan
8.1 Japan Skin Cancer Market Size (2014-2019)
8.2 Skin Cancer Key Players in Japan
8.3 Japan Skin Cancer Market Size by Type
8.4 Japan Skin Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Skin Cancer Market Size (2014-2019)
9.2 Skin Cancer Key Players in Southeast Asia
9.3 Southeast Asia Skin Cancer Market Size by Type
9.4 Southeast Asia Skin Cancer Market Size by Application
10 India
10.1 India Skin Cancer Market Size (2014-2019)
10.2 Skin Cancer Key Players in India
10.3 India Skin Cancer Market Size by Type
10.4 India Skin Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Skin Cancer Market Size (2014-2019)
11.2 Skin Cancer Key Players in Central & South America
11.3 Central & South America Skin Cancer Market Size by Type
11.4 Central & South America Skin Cancer Market Size by Application
12 International Players Profiles
12.1 F. Hoffmann-la Roche Ltd. (Switzerland)
12.1.1 F. Hoffmann-la Roche Ltd. (Switzerland) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Skin Cancer Introduction
12.1.4 F. Hoffmann-la Roche Ltd. (Switzerland) Revenue in Skin Cancer Business (2014-2019)
12.1.5 F. Hoffmann-la Roche Ltd. (Switzerland) Recent Development
12.2 Novartis International AG (Switzerland)
12.2.1 Novartis International AG (Switzerland) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Skin Cancer Introduction
12.2.4 Novartis International AG (Switzerland) Revenue in Skin Cancer Business (2014-2019)
12.2.5 Novartis International AG (Switzerland) Recent Development
12.3 Sun Pharma Industries Ltd. (India)
12.3.1 Sun Pharma Industries Ltd. (India) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Skin Cancer Introduction
12.3.4 Sun Pharma Industries Ltd. (India) Revenue in Skin Cancer Business (2014-2019)
12.3.5 Sun Pharma Industries Ltd. (India) Recent Development
12.4 Elekta AB (Sweden)
12.4.1 Elekta AB (Sweden) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Skin Cancer Introduction
12.4.4 Elekta AB (Sweden) Revenue in Skin Cancer Business (2014-2019)
12.4.5 Elekta AB (Sweden) Recent Development
12.5 Varian Medical Systems Inc. (US)
12.5.1 Varian Medical Systems Inc. (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Skin Cancer Introduction
12.5.4 Varian Medical Systems Inc. (US) Revenue in Skin Cancer Business (2014-2019)
12.5.5 Varian Medical Systems Inc. (US) Recent Development
12.6 Cannabis Science Inc. (US)
12.6.1 Cannabis Science Inc. (US) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Skin Cancer Introduction
12.6.4 Cannabis Science Inc. (US) Revenue in Skin Cancer Business (2014-2019)
12.6.5 Cannabis Science Inc. (US) Recent Development
12.7 Cellceutix Corp. (US)
12.7.1 Cellceutix Corp. (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Skin Cancer Introduction
12.7.4 Cellceutix Corp. (US) Revenue in Skin Cancer Business (2014-2019)
12.7.5 Cellceutix Corp. (US) Recent Development
12.8 LEO Pharma A/S (Denmark)
12.8.1 LEO Pharma A/S (Denmark) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Skin Cancer Introduction
12.8.4 LEO Pharma A/S (Denmark) Revenue in Skin Cancer Business (2014-2019)
12.8.5 LEO Pharma A/S (Denmark) Recent Development
12.9 Moberg Pharma AB (Sweden)
12.9.1 Moberg Pharma AB (Sweden) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Skin Cancer Introduction
12.9.4 Moberg Pharma AB (Sweden) Revenue in Skin Cancer Business (2014-2019)
12.9.5 Moberg Pharma AB (Sweden) Recent Development
12.10 Mylan Pharmaceutical Inc. (US)
12.10.1 Mylan Pharmaceutical Inc. (US) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Skin Cancer Introduction
12.10.4 Mylan Pharmaceutical Inc. (US) Revenue in Skin Cancer Business (2014-2019)
12.10.5 Mylan Pharmaceutical Inc. (US) Recent Development
12.11 Oncothyreon Inc. (US)
12.12 Eli Lilly and Co. (US)
12.13 Bristol Myers Squibb Co. (US)
12.14 Boehringer Ingelheim GmbH (Germany)
12.15 Aqua Pharmaceuticals LLC (US)
12.16 Valeant Pharmaceuticals Inc (Canada)
12.17 Meda AB (US)
12.18 iCAD Inc. (Sweden)
12.19 Merck & Co. Inc. (US)
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Skin Cancer Key Market Segments
Table Key Players Skin Cancer Covered
Table Global Skin Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Skin Cancer Market Size Market Share by Type 2014-2025
Figure Basal Cell Carcinoma Figures
Table Key Players of Basal Cell Carcinoma
Figure Squamous Cell Carcinoma Figures
Table Key Players of Squamous Cell Carcinoma
Table Global Skin Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinics Case Studies
Figure Diagnostic Centers Case Studies
Figure Cancer Research Institute Case Studies
Figure Skin Cancer Report Years Considered
Table Global Skin Cancer Market Size 2014-2025 (Million US$)
Figure Global Skin Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Skin Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Skin Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Skin Cancer Market Share by Regions 2014-2019
Figure Global Skin Cancer Market Share by Regions 2014-2019
Figure Global Skin Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Skin Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Skin Cancer Market Share by Manufacturers (2014-2019)
Figure Global Skin Cancer Market Share by Manufacturers in 2018
Table Global Skin Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Skin Cancer Product/Solution/Service
Table Date of Enter into Skin Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Skin Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Skin Cancer Market Size Share by Type (2014-2019)
Figure Global Skin Cancer Market Size Market Share by Type (2014-2019)
Table Global Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Skin Cancer Market Size Share by Application (2014-2019)
Figure Global Skin Cancer Market Size Market Share by Application (2014-2019)
Figure Global Skin Cancer Revenue Market Share by Application in 2018
Figure United States Skin Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Skin Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Skin Cancer Market Share (2018-2019)
Table United States Skin Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Skin Cancer Market Share by Type (2014-2019)
Table United States Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Skin Cancer Market Share by Application (2014-2019)
Figure Europe Skin Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Skin Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Skin Cancer Market Share (2018-2019)
Table Europe Skin Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Skin Cancer Market Share by Type (2014-2019)
Table Europe Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Skin Cancer Market Share by Application (2014-2019)
Figure China Skin Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Skin Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Skin Cancer Market Share (2018-2019)
Table China Skin Cancer Market Size by Type (2014-20189) (Million US$)
Table China Skin Cancer Market Share by Type (2014-2019)
Table China Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table China Skin Cancer Market Share by Application (2014-2019)
Figure Japan Skin Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Skin Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Skin Cancer Market Share (2018-2019)
Table Japan Skin Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Skin Cancer Market Share by Type (2014-2019)
Table Japan Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Skin Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Skin Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Skin Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Skin Cancer Market Share (2018-2019)
Table Southeast Asia Skin Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Skin Cancer Market Share by Type (2014-2019)
Table Southeast Asia Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Skin Cancer Market Share by Application (2014-2019)
Figure India Skin Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Skin Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Skin Cancer Market Share (2018-2019)
Table India Skin Cancer Market Size by Type (2014-2019) (Million US$)
Table India Skin Cancer Market Share by Type (2014-2019)
Table India Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table India Skin Cancer Market Share by Application (2014-2019)
Figure Central & South America Skin Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Skin Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Skin Cancer Market Share (2018-2019)
Table Central & South America Skin Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Skin Cancer Market Share by Type (2014-2019)
Table Central & South America Skin Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Skin Cancer Market Share by Application (2014-2019)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Company Details
Table F. Hoffmann-la Roche Ltd. (Switzerland) Revenue in Skin Cancer Business (2014-2019) (Million US$)
Figure F. Hoffmann-la Roche Ltd. (Switzerland) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Recent Development
Table Novartis International AG (Switzerland) Company Details
Table Novartis International AG (Switzerland) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Novartis International AG (Switzerland) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Novartis International AG (Switzerland) Recent Development
Table Sun Pharma Industries Ltd. (India) Company Details
Table Sun Pharma Industries Ltd. (India) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Sun Pharma Industries Ltd. (India) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Sun Pharma Industries Ltd. (India) Recent Development
Table Elekta AB (Sweden) Company Details
Table Elekta AB (Sweden) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Elekta AB (Sweden) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Elekta AB (Sweden) Recent Development
Table Varian Medical Systems Inc. (US) Company Details
Table Varian Medical Systems Inc. (US) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Varian Medical Systems Inc. (US) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Varian Medical Systems Inc. (US) Recent Development
Table Cannabis Science Inc. (US) Company Details
Table Cannabis Science Inc. (US) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Cannabis Science Inc. (US) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Cannabis Science Inc. (US) Recent Development
Table Cellceutix Corp. (US) Company Details
Table Cellceutix Corp. (US) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Cellceutix Corp. (US) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Cellceutix Corp. (US) Recent Development
Table LEO Pharma A/S (Denmark) Company Details
Table LEO Pharma A/S (Denmark) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure LEO Pharma A/S (Denmark) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table LEO Pharma A/S (Denmark) Recent Development
Table Moberg Pharma AB (Sweden) Company Details
Table Moberg Pharma AB (Sweden) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Moberg Pharma AB (Sweden) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Moberg Pharma AB (Sweden) Recent Development
Table Mylan Pharmaceutical Inc. (US) Company Details
Table Mylan Pharmaceutical Inc. (US) Revenue in Skin Cancer Business (2014-2019)(Million US$)
Figure Mylan Pharmaceutical Inc. (US) Revenue Growth Rate in Skin Cancer Business (2014-2019)
Table Mylan Pharmaceutical Inc. (US) Recent Development
Table Oncothyreon Inc. (US) Company Details
Table Eli Lilly and Co. (US) Company Details
Table Bristol Myers Squibb Co. (US) Company Details
Table Boehringer Ingelheim GmbH (Germany) Company Details
Table Aqua Pharmaceuticals LLC (US) Company Details
Table Valeant Pharmaceuticals Inc (Canada) Company Details
Table Meda AB (US) Company Details
Table iCAD Inc. (Sweden) Company Details
Table Merck & Co. Inc. (US) Company Details
Table Global Skin Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Skin Cancer Market Size Share by Regions (2019-2025)
Figure Global Skin Cancer Market Size Share by Regions in 2025
Figure United States Skin Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Skin Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Skin Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Skin Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Skin Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Skin Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Skin Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Skin Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Skin Cancer Market Size by Product (2019-2025)
Figure Global Skin Cancer Market Size by Product in 2025
Table Global Skin Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Skin Cancer Market Size by Application (2019-2025)
Figure Global Skin Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の皮膚がんの診断と治療市場：市場規模・現状・予測 Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million …- 世界の皮膚がん診断市場2019 The global Skin Cancer Diagnostics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Skin Cancer Diagnostics market status and forecast, categorizes the global Skin Cancer Diagnostics market s…
- 世界の頭頸部治療の扁平上皮がん市場：市場規模・現状・予測 Head and neck cancer usually occurs in the squamous cells present inside the mouth, nose and throat. These squamous cells are usually known as squamous cell carcinoma of the head and neck.In 2018, the global Squamous Cell Carcinoma of the Head and Neck Treatment market size was xx million US$ and it…
- 世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…
- 世界の移行上皮がん治療薬市場：市場規模・現状・予測 Transitional cell carcinoma (TCC) occur in the different parts of urinary tract, which include kidney, bladder, or urethra.Market revenue drivers for the transitional cell cancer therapeutics market include increase in environmental pollution levels coupled with high rates of cigarette smoking. In 2…